Published on FierceBiotech (http://www.fiercebiotech.com)

SPOTLIGHT: FDA panel votes to restrict Ketek

By admin

Created Dec 17 2006 - 7:01pm

An FDA advisory panel has voted to restrict the use of Sanofi-Aventis' controversial antibiotic Ketek. Panel members said that the risks outweighed the benefits [1] of using Ketek against acute bacterial sinusitis and acute bacterial exacerbation of chronic bronchitis. Report [2]

antibiotic
FDA
Ketek
Regulators
Sanofi

Source URL: http://www.fiercebiotech.com/story/spotlight-fda-panel-votes-to-restrict-ketek/2006-12-18

Links:
[1] http://www.fiercebiotech.com/story/senator-makes-dramatic-demand-in-ketek-probe/2006-06-15
[2] http://www.thestreet.com/_googlen/newsanalysis/pharmaceuticals/10328300.html?cm_ven=GOOGLEN&cm_cat=FREE&cm_ite=NA